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ABSTRACT
The objective of this study was to evaluate the po-
tential benefits of supplementing glutamic acid in milk 
replacers (MR) with respect to calf performance, in-
testinal permeability, and metabolism. Sixty Holstein 
male calves (3 ± 1.3 d old and 45 ± 5.9 kg body weight) 
were individually housed and fed a control MR without 
AA supplementation (24.8% crude protein and 19.1% 
fat, dry matter basis), or MR supplemented with 0.3% 
glutamic acid (25.1% crude protein and 20.3% fat, dry 
matter basis). Animals followed the same MR feeding 
program and were weaned at 56 d of the study. The 
amount of starter concentrate offered was restricted to 
limit the effect of concentrate intake on calf metabo-
lism. Individual daily consumption and weekly body 
weight were measured, and 4 h after the morning feed-
ing, blood samples were obtained at 14 and 35 d to 
determine general biochemical parameters and plasma 
AA concentrations. On d 10 of the study, we conducted 
an intestinal permeability test by including 21 g of 
lactulose and 4.2 g of d-mannitol as markers in the 
MR. We found no differences in calf performance or in 
intestinal permeability (measured as lactulose: mannitol 
ratio). Serum glucose concentration was greater in un-
supplemented calves than in Glu-supplemented calves. 
At 14 d, the proportion of plasma Leu was greater in 
Glu-supplemented calves; the proportion of Ile tended 
to be greater in Glu-supplemented calves; and the pro-
portion of Met tended to be greater in unsupplemented 
calves. We observed no other differences. Small changes 
occurred in AA metabolism when supplementing calf 
MR with 0.3% glutamic acid, without leading to im-
provements in calf performance or changes in intestinal 
permeability.
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Short Communication
In recent decades, research has focused on improving 
newborn calf health (Cho and Yoon, 2014; Harris et 
al., 2017), especially diarrhea during the first 3 wk of 
life (Gulliksen et al., 2009; Mahendran et al., 2017). 
Colostrum is an excellent source of nutrients, but also 
a pivotal source of antimicrobials, immune-stimulating 
factors, and growth factors protecting against infec-
tions (Menchetti et al., 2016) that promote epithelial 
cell proliferation (Altomare et al., 2016) and matura-
tion of the gastrointestinal tract (Blum, 2006; Blum 
and Baumrucker, 2008; Hammon et al., 2013). To 
support gastrointestinal tract development beyond co-
lostrum feeding, glutamic acid might represent a good 
supplement, because it is a major oxidative fuel for 
the intestine (Burrin and Stoll, 2009) and immune cells 
(Huang et al., 2003). Furthermore, glutamic acid has 
been shown to act as a protector for intestinal mucosa, 
maintaining intestinal barrier function (Wang et al., 
2014), and as a mediator of immune response (Ruth 
and Field, 2013). In addition, glutamic acid is a precur-
sor of glutamine, an AA considered to be essential for 
neonates (Wu et al., 2014). The objective of this study 
was to evaluate the potential effects of glutamic acid 
supplementation on calf performance, metabolism, and 
intestinal permeability.
Sixty male Holstein newborn calves from a single 
commercial farm were enrolled in this study between 
April and September 2017. Calves were blocked by ar-
rival at the farm, so that the same number of calves 
was enrolled per treatment group in each batch. Within 
the first 2 h after birth, calves were fed 3.6 ± 0.09 L of 
frozen colostrum. Then, they were offered 2 additional 
colostrum feedings of 3 L. After 3 colostrum feedings, 
calves were fed 4 L/d of a commercial milk replacer 
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(23.8% CP, 18% fat, DM basis; Nantamilk Platino; 
Tres Cantos, Madrid, Spain) at 12.5% DM concentra-
tion distributed in 2 feedings until they were trans-
ported to IRTA facilities at Torre Marimon (Caldes 
de Montbui, Spain). Calves were managed according 
to common animal management conditions under the 
supervision of IRTA technicians and with the approval 
of the animal care committee of the Catalonia govern-
ment (authorization code 9733). On arrival, calves were 
3 ± 1.3 d old and weighed 45 ± 5.9 kg. They were 
individually housed in pens (1 × 1.6 m) equipped with 
1 bucket for water, 1 for concentrate, and 1 for chopped 
forage. Pens were bedded with sawdust on a daily basis. 
For the duration of the study, calves had ad libitum ac-
cess to water. Chopped barley straw (2.37% CP, 87.7% 
NDF, 59.62% ADF; DM basis) was restricted for calves 
from d 1 to 35 d to 7.5% of the daily offer of solid feed, 
and then provided ad libitum from 36 d until the end 
of the study. Straw was chopped using a forage chopper 
(Seco, Curtalo, Italy) to reach the following particle 
size distribution: 66.0% > 20 mm, 10.0% between 8 
and 20 mm, and 24.0% < 8 mm, determined using a 
Penn State particle separator. The amount of pelleted 
starter feed (19.3% CP, 16.2% NDF, 5.8% ADF, 6.3 
ash, 3.5% fat; DM basis) available to calves was re-
stricted to minimize potential confounding of effects 
on calf metabolism because of differences in solid feed 
intake. Solid feed was restricted according to the follow-
ing schedule: from d 1 to 7, calves were offered a maxi-
mum of 100 g of starter feed; from 8 to 14 d, 300 g/d; 
from 15 to 21 d, 500 g/d; from 22 to 28 d, 600 g/d; from 
29 to 35 d, 800 g/d; and starter feed was provided ad 
libitum thereafter. Calves were bottle-fed milk replacer 
(MR) according to the following feeding program: 2 L 
of MR twice a day at 12.5% concentration of solids for 
the first 4 d; then, MR was increased to 5 L/d at 12.5% 
concentration for the next 3 d; then increased to 6 L/d 
at 12.5% concentration for the next 7 d; and finally 
increased to 2 meals per day of 3 L at 15% concentra-
tion until 49 d of age. After that, MR was limited to a 
single meal of 3 L (also at 15% concentration) until 56 
d, when calves were fully weaned. Calves were fed MR 
(47.2% lactose, 25.1% CP, 20.3% fat, 7.5 ash; DM basis; 
Nukamel, Weert, the Netherlands) supplemented with 
0.3% glutamic acid (Fuxing Pharmaceutical, Ningxia, 
China) replacing skim milk powder (GLU) or MR 
(48.2% lactose, 24.8% CP, 19.1% fat, 7.5 ash; DM basis; 
Nukamel) with no AA supplementation (control). Milk 
replacers were formulated to have the same nutrient 
composition but a different AA profile (Table 1).
Calves were weighed using an electronic scale (Mobba 
SC-01, Badalona, Spain) when they arrived at the farm 
and weekly basis. Individual consumption of MR and 
solid feed were determined daily by measuring leftovers. 
A daily score for digestive health status was recorded 
[1 = no digestive disorder; 2 = moderate signs (soft/
watery diarrhea but calf reacting to caretaker stimu-
lus); and 3 = severe signs (watery or bloody diarrhea, 
and calf listless)]. At 14 and 35 d of the study, blood 
samples were obtained 4 h after the morning feeding 
of MR. Samples were collected in 10-mL Vacutainer 
tubes (BD Diagnostics, Wokingham, UK) without anti-
coagulant to obtain serum and determine biochemistry 
profiles, and with lithium heparin to determine plasma 
AA concentrations. Serum and plasma were obtained 
by centrifugation at 1,500 × g for 10 min and stored 
in aliquots at −20°C until further analysis. At 10 d 
of study, a permeability test was conducted by adding 
21 g of lactulose and 4.2 g of d-mannitol to the MR 
as markers (Araujo et al., 2015). Blood samples were 
collected in Vacutainer (BD Diagnostics) tubes without 
additives 1 h after the morning feeding of MR to assess 
serum concentration of lactulose and d-mannitol. Feeds 
were analyzed for DM (4 h at 103°C), ash (550°C cal-
cination), and CP using a Kjeldahl automatic distiller 
(Kjeltec Auto 1030 Analyzer, Tecator, Valley City, 
OH) with copper sulfate/selenium as a catalyst instead 
of copper sulfate/titanium dioxide (method 988.05; 
AOAC, 1990); NDF was analyzed with sodium sulfite 
and heat-stable α-amylase (Van Soest et al., 1991); 
ADF was analyzed following the method of Robertson 
and Van Soest (1981); ether extract was analyzed using 
petroleum ether for distillation instead of diethyl ether 
with a previous acid hydrolysis (method 920.39; AOAC, 
1990); and total AA and total tryptophan concentra-
tions were determined using fluorescence HPLC and 
UV HPLC, respectively, after strong acid hydrolysis 
with orthophthaldialdehyde and 9-fluorenyl-methoxy-
carbonyl chloride (UNE-EN-ISO 13903:2005 and UNE-
EN-ISO 13904:2005, respectively; UNE, 2005a,b). We 
determined serum concentrations of lactulose and d-
mannitol using ultra-HPLC mass spectrometry (Xevo 
G2 Tof; Waters, Milford, MA) with an electrospray ion-
ization source operating in negative mode following the 
method of Araujo et al. (2015). We measured plasma 
AA by HPLC as described in Yu et al. (2018) using 
an Elite LaCHrom (Hitachi, Tokyo, Japan) equipped 
with a UV detector (L-24200; Hitachi) with a Novapak 
C18 column (300 mm × 3.9 mm; Waters). We used 
EZChrom Elite system V3.1.7 software (Agilent, Santa 
Clara, CA) for system control and data acquisition. 
Serum biochemistry analyses were performed using an 
Olympus AU400 analyzer (Beckman Coulter, Ham-
burg, Germany) using the Olympus System Reagent 
(Beckman Coulter).
Performance and blood data were analyzed using a 
mixed-effects model accounting for the fixed effects of 
treatment, time of measurement, their 2-way interac-
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tion, and the random effect of calf, with the arrival 
batch of calves at experimental farm as a block. Time 
entered the model as a repeated measure using an au-
toregressive covariance matrix. Digestive health status 
scores were analyzed with a generalized linear model, 
considering glutamic acid supplementation as a fixed 
effect and the number of days with a digestive score >1 
per calf within a defined period of time as the depen-
dent variable.
No benefits in calf performance were observed when 
MR was supplemented with 0.3% glutamic acid (Table 
2). Despite the fact that we limited the solid feed of-
fered, some calves did not consume all of their feed 
allowances on some days, which added some variation 
to the results (although this variation would have been 
much greater had we not limited the solid feed offered). 
We found an increase in straw intake in the last 2 wk of 
the study in GLU calves compared with control calves, 
but this difference did not lead to improvements in 
growth performance. The prevalence of digestive health 
scores greater than 1 was similar for both treatment 
groups in the 3 periods studied (d 1 to 14, d 15 to 35, 
and d 36 to 56, Table 2). Intestinal permeability was 
also similar in both treatment groups at 10 d (Table 2). 
Most of the analyzed biochemical parameters were also 
similar between treatments (insulin, urea, creatinine, 
cholesterol, triglycerides, fatty acids, total proteins, 
hepatic enzymes, and glutathione peroxidase), with 
the exception of serum glucose concentration, which 
was lower (P < 0.05) in GLU calves compared with 
control calves (Table 2). Most plasma concentration 
AA profiles were similar for both treatments (Table 3), 
including glutamic acid. However, Leu and Ile plasma 
concentration profiles were lower (P < 0.05) or tended 
(P = 0.054) to be lower in control than in GLU calves 
at 14 d, and similar at 35 d. Although not significant, 
the Val plasma concentration profile showed the same 
numerical trend (P = 0.11) as plasma Leu and Ile con-
centration profiles at 14 d. The proportion of plasma 
Met tended to be greater (P = 0.09) in control calves 
compared with GLU calves.
This study was inspired by the reported benefits of 
glutamic acid in intestinal cells as a main energy source. 
However, we observed changes in only the plasma 
branched-chain AA profile at 14 d of that study, and a 
trend for a higher Met plasma profile. We did not expect 
to observe changes in plasma Glu concentrations, be-
cause enterocytes use most of the glutamic acid intake, 
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Table 1. Ingredients and AA composition of milk replacers, unsupplemented (control) or supplemented with 
0.3% glutamic acid (GLU)
Item Control GLU Starter feed
Ingredient composition, %
 Skim milk powder 39 38.7 —
 Whey protein concentrate 35 15 15 —
 Whey protein concentrate 60 4 4 —
 Fatted whey 50 39 39 —
 Premix1 3 3 —
 Glutamic acid 0 0.3 —
AA composition, g/100 g (DM basis)
 Asp 2.15 2.17 1.55
 Glu 4.94 5.14 3.33
 Ser 1.30 1.29 0.85
 His 0.54 0.57 0.41
 Gly 0.60 0.54 0.76
 Thr 1.28 1.30 0.70
 Arg 0.73 0.76 1.17
 Ala 0.95 0.93 0.79
 Tyr 0.86 0.89 0.58
 Val 1.38 1.47 0.77
 Met 0.57 0.58 0.21
 Phe 0.98 0.96 0.82
 Ile 1.33 1.32 0.66
 Leu 2.46 2.39 1.35
 Lys 2.14 2.03 1.06
 Hyp <0.030 <0.030 0.043
 Pro 2.13 2.05 1.05
 Trp 0.30 0.36 0.20
1Vitamin A 25,000 IU, vitamin D3 4,500 IU, vitamin C 300 mg/kg, vitamin B1 16 mg/kg, vitamin B2 10 mg/
kg, vitamin B6 10 mg/kg, vitamin B12 80 µg/kg, vitamin K3 5.5 mg/kg, biotin 160 µg/kg, niacin 50 mg/kg, 
pantothenic acid 23 mg/kg, folic acid 1 mg/kg, Fe 150 mg/kg, Cu 10 mg/kg, Zn 170 mg/kg, Mn 40 mg/kg, I 
1.3 mg/kg, Se 0.4 mg/kg.
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and small fractions of luminally administered Glu are 
absorbed into the mesenteric venous blood (Janeczko 
et al., 2007), even if Glu intake is excessive (Burrin 
and Stoll, 2009). Moreover, we observed no differences 
in serum urea concentrations, suggesting that glutamic 
acid supplementation did not increase AA oxidation. 
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Table 2. Performance, feed intake, and serum biochemical parameters of calves fed an unsupplemented milk replacer (control) or a milk replacer 





Control GLU T W T × W
Performance and feed intake     
 Initial BW, kg 44.4 44.9 1.14 0.789 — —
 Final BW, kg 89.0 89.4 0.74 0.448 <0.001 0.621
 Initial hip height, m 0.82 0.82 0.007 0.498 — —
 Final hip height, m 0.93 0.93 0.004 0.846 <0.001 0.634
 ADG, g/d 800 809 18.5 0.731 <0.001 0.609
 DMI, g/d       
  Milk replacer 750 749 1.8 0.663 <0.001 0.564
  Starter feed 475 442 36.7 0.520 <0.001 0.808
  Straw 32 37 3.4 0.251 <0.001 0.008
  Total 1,258 1,227 37.5 0.559 <0.001 0.896
 Gain: feed ratio 0.66 0.68 0.011 0.108 <0.001 0.591
 Fecal score (period 1)2 0.10 0.11 0.015 0.65 — —
 Fecal score (period 2)3 0.10 0.08 0.011 0.24 — —
 Fecal score (period 3)4 0.05 0.04 0.008 0.29 — —
Serum       
 Lactulose: mannitol ratio 2.5 2.2 0.19 0.12 — —
 Glucose, mmol/L 6.38 6.00 0.133 0.049 0.920 0.158
 Urea, mmol/L 2.49 2.62 0.122 0.586 0.099 0.872
1T = effect of glutamic acid supplementation; T × W = effect of the interaction of glutamic acid supplementation with week of study; W = 
effect of week of study.
2Prevalence of fecal score >1 of calves in each treatment from 1 to 14 d of the study.
3Prevalence of fecal score >1 of calves in each treatment from 15 to 35 d of the study.
4Prevalence of fecal score >1 of calves in each treatment from 36 to 56 d of the study.
Table 3. Plasma AA profile at 14 and 35 d of the study in calves fed an unsupplemented milk replacer 






Control GLU T D T × D
Asn/Ser 5.86 5.86 0.121 0.995 0.179 0.748
Glu 2.64 2.72 0.106 0.592 <0.001 0.797
Gly 11.82 11.51 0.303 0.469 0.03 0.162
Gln 11.40 11.36 0.224 0.885 0.209 0.156
His 2.40 2.32 0.069 0.432 <0.001 0.751
Arg 7.06 6.97 0.288 0.834 0.195 0.771
Cit 2.44 2.68 0.104 0.119 <0.001 0.418
Thr 6.62 6.49 0.237 0.708 <0.001 0.957
Ala 8.44 8.43 0.210 0.981 0.062 0.506
Pro 4.45 4.47 0.090 0.878 0.020 0.948
Tyr 2.22 2.25 0.068 0.709 <0.001 0.779
Val 6.68 6.88 0.160 0.384 0.003 0.112
Met 1.45 1.28 0.074 0.093 <0.001 0.364
Orn 2.40 2.46 0.094 0.656 <0.001 0.888
Lys 7.76 7.44 0.224 0.315 0.072 0.898
Cys 4.46 4.67 0.141 0.283 <0.001 0.743
Ile 3.73 3.82 0.074 0.405 0.059 0.054
Leu 4.76 4.90 0.119 0.388 0.024 0.022
Phe 1.99 2.00 0.060 0.865 0.003 0.598
Trp 1.44 1.52 0.042 0.199 <0.001 0.991
1D = effect of the sampling day; T = effect of feeding milk replacer supplemented or not with 0.3% glutamic 
acid; T × D = effect of the interaction of glutamic acid supplementation and sampling day.
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In contrast, when greater amounts (1%) of glutamine 
supplementation were used in a soy protein concentrate 
MR, an increase in plasma urea N concentration was 
observed (Drackley et al., 2006). Similar to our results, 
Burrin and Stoll (2009) and Rezaei et al. (2013) also re-
ported that an increase of key gut oxidative substrates 
reduced the gut metabolism of branched-chain AA, 
resulting in increased plasma levels. Branched-chain 
AA are known to upregulate glucose transporters and 
activate glucose synthesis (Holeček, 2018), and this 
might explain the lower glucose plasma concentrations 
in the GLU calves compared with control calves. Al-
though plasma Met concentrations also increased when 
glutamate was fed to postweaned pigs in a previous 
study (Rezaei et al., 2013), the observed trend in the 
present study was in the opposite direction, suggesting 
that Met might be a limiting AA in calves.
The lack of benefits associated with glutamic acid 
supplementation in the present study might be ex-
plained because of an insufficient supply of glutamic 
acid in the MR, as reported in Rezaei et al. (2013) 
which supplemented glutamate in pigs at 0.5%, rather 
than 1%, 2%, or 4% supplemented doses. Another ex-
planation might be that calves in the present study 
were not in a stressful situation (e. g., illness, injury, 
heat stress), in which Glu or Gln requirements increase, 
as observed in broilers under heat stress conditions 
(Porto et al., 2015).
In conclusion, under commercial rearing conditions, 
supplementation with 0.3% glutamic acid in an all-milk 
protein MR with 25% CP and 19.5% fat did not im-
prove calf performance, but did alter the metabolism of 
some branched-chain AA.
ACKNOWLEDGMENTS
This is research was supported by the Spanish Min-
istry of Economy and Competitivity (AGL2015-68463-
C2-1-P and AGL2015-68463-C2-2). Partial support was 
also received from the CERCA program from Gener-
alitat de Catalunya (Barcelona, Spain). We also thank 
Jordi Casino and Germán Antúnez from IRTA for their 
help with calf management and care; Granja Murucuc 
for providing the calves; and Kuai and Yolanda Saco 
from UAB for the laboratory analyses.
REFERENCES
Altomare, A., E. Fasoli, M. Colzami, X. M. Paredes Parra, M. Ferrari, 
F. Cilurzo, C. Rumio, L. Cannizzaro, M. Carini, P. G. Righetti, 
and G. Aldini. 2016. An in-depth proteomic analysis based on 
ProteoMiner, affinity chromatography and nano-HPLC-MS/MS 
to explain the potential health benefits of bovine colostrum. J. 
Pharm. Biomed. Anal. 121:297–306. https: / / doi .org/ 10 .1016/ j 
.jpba .2016 .01 .013.
AOAC. 1990. Official Methods of Analysis. 15th ed. Association of Of-
ficial Analytical Chemists (AOAC), Arlington, VA.
Araujo, G., C. Yunta, M. Terré, A. Mereu, I. Ipharraguerre, and A. 
Bach. 2015. Intestinal permeability and incidence of diarrhea in 
newborn calves. J. Dairy Sci. 98:7309–7317. https: / / doi .org/ 10 
.3168/ jds .2015 -9666.
Blum, J. W. 2006. Nutritional physiology of neonatal calves. J. Anim. 
Physiol. Anim. Nutr. (Berl.) 90:1–11. https: / / doi .org/ 10 .1111/ j 
.1439 -0396 .2005 .00614 .x.
Blum, J. W., and C. R. Baumrucker. 2008. Insulin-like growth factors 
(IGFs), IGF binding proteins, and other endocrine factors in milk: 
Role in the newborn. Adv. Exp. Med. Biol. 606:397–422. https: / / 
doi .org/ 10 .1007/ 978 -0 -387 -74087 -4 _16.
Burrin, D. G., and B. Stoll. 2009. Metabolic fate and function of 
dietary glutamate in the gut. Am. J. Clin. Nutr. 90:850S–856S. 
https: / / doi .org/ 10 .3945/ ajcn .2009 .27462Y.
Cho, Y., and K. J. Yoon. An overview of calf diarrhea—Infectious 
etiology, diagnosis, and intervention. J. Vet. Sci. 15:1–17. https: / / 
doi .org/ 10 .4142/ jvs .2014 .15 .1 .1.
Drackley, J. K., R. M. Blome, K. S. Bartlett, and K. L. Bailey. 2006. 
Supplementation of 1% L-Glutamine to milk replacer does not 
overcome the growth depression in calves caused by soy protein 
concentrate. J. Dairy Sci. 89:1688–1693. https: / / doi .org/ 10 .3168/ 
jds .S0022 -0302(06)72236 -6.
Gulliksen, S. M., K. I. Lie, T. Loken, and O. Osteras. 2009. Calf mor-
tality in Norwegian dairy herds. J. Dairy Sci. 92:2782–2795. https: 
/ / doi .org/ 10 .3168/ jds .2008 -1807.
Hammon, H. M., J. Steinhoff-Wagner, J. Flor, U. Schönhusen, and C. 
C. Metges. 2013. Role of colostrum and colostrum components on 
glucose metabolism in neonatal calves. J. Anim. Sci. 91:685–695. 
https: / / doi .org/ 10 .2527/ jas .2012 -5758.
Harris, T. L., Y. Liang, K. P. Sharon, M. D. Sellers, I. Yoon, M. F. 
Scott, J. A. Carroll, and M. A. Ballou. 2017. Influence of Sac-
charomyces cerevisiae fermentation products, SmartCare in milk 
replacer and Original XPC in calf starter, on the performance 
and health of preweaned Holstein calves challenged with Salmo-
nella enterica serotype Typhimurium. J. Dairy Sci. 100:7154–7164. 
https: / / doi .org/ 10 .3168/ jds .2016 -12509.
Holeček, M. 2018. Branched-chain amino acids in health and disease: 
Metabolism, alterations in blood plasma, and as supplements. 
Nutr. Metab. (Lond.) 15:33. https: / / doi .org/ 10 .1186/ s12986 -018 
-0271 -1.
Huang, Y., X. M. Shao, and J. Neu. 2003. Immunonutrients and 
neonates. Eur. J. Pediatr. 162:122–128. https: / / doi .org/ 10 .1007/ 
s00431 -002 -1128 -0.
Janeczko, M. J., B. Stoll, X. Chang, X. Guan, and D. G. Burrin. 2007. 
Extensive gut metabolism limits the intestinal absorption of exces-
sive supplemental dietary glutamate loads in infant pigs. J. Nutr. 
137:2384–2390. https: / / doi .org/ 10 .1093/ jn/ 137 .11 .2384.
Mahendran, S. A., R. Booth, L. Beekhuis, A. Manning, T. Blackmore, 
A. Vanhoudt, and N. Bell. 2017. Assessing the effects of weekly 
preweaning health score on dairy calf mortality and productiv-
ity parameters: Cohort study. Vet. Rec. https: / / doi .org/ 10 .1136/ 
vr .104197.
Menchetti, L., G. Traina, G. Tomasello, P. Casagrande-Proietti, L. 
Leonardi, O. Barbato, and G. Brecchia. 2016. Potential benefits of 
colostrum in gastrointestinal diseases. Front. Biosci. (Schol. Ed.) 
8:331–351.
Porto, M. L., P. E. N. Givisiez, E. P. Saraiva, F. G. P. Costa, A. L. B. 
Moreira Filho, M. F. S. Andrade, P. A. Brandao, and R. R. Guer-
ra. 2015. Glutamic acid improves body weight gain and intestinal 
morphology of broiler chickens submitted to heat stress. Braz. J. 
Poult. Sci. 17:355–362. https: / / doi .org/ 10 .1590/ 1516 -635x1703355 
-362.
Rezaei, R., D. A. Knabe, C. D. Tekwe, S. Dahanayaka, M. D. Ficken, 
S. E. Fielder, S. J. Eide, S. L. Lovering, and G. Wu. 2013. Di-
etary supplementation with monosodium glutamate is safe and 
Ahangarani et al.: SHORT COMMUNICATION: GLUTAMIC ACID IN MILK REPLACER
438
Journal of Dairy Science Vol. 103 No. 1, 2020
improves growth performance in postweaning pigs. Amino Acids 
44:911–923. https: / / doi .org/ 10 .1007/ s00726 -012 -1420 -x.
Robertson, J. B., and P. J. Van Soest. 1981. The detergent system of 
analysis. Pages 123–158 in The Analysis of Dietary Fiber in Food. 
W. P. T. James and O. Theander, ed. Marcel Dekker, New York, 
NY.
Ruth, M. R., and C. J. Field. 2013. The immune modifying effects of 
amino acids on gut-associated lymphoid tissue. J. Anim. Sci. Bio-
technol. 4:27. https: / / doi .org/ 10 .1186/ 2049 -1891 -4 -27.
UNE. 2005a. Animal feeding stuffs. Determination of amino acids con-
tent. ISO13903: 2005. UNE, Madrid, Spain.
UNE. 2005b. Animal feeding stuffs. Determination of tryptophan con-
tent. ISO13904: 2005. UNE, Madrid, Spain.
Van Soest, P. J., J. B. Robertson, and B. A. Lewis. 1991. Methods for 
dietary fiber, neutral detergent fiber, and nonstarch polysaccha-
rides in relation to animal nutrition. J. Dairy Sci. 74:3583–3597.
Wang, B., G. Wu, Z. Zhou, Z. Dai, Y. Sun, Y. Ji, W. Li, W. Wang, 
C. Liu, F. Han, and Z. Wu. 2014. Glutamine and intestinal barrier 
function. Amino Acids 47:2143–2154. https: / / doi .org/ 1007/ s00726 
-014 -1773 -4.
Wu, G., F. W. Bazer, Z. Dai, D. Li, J. Wang, and Z. Wu. 2014. Amino 
acid nutrition in animals: Protein synthesis and beyond. Annu. 
Rev. Anim. Biosci. 2:387–417. https: / / doi .org/ 10 .1146/ annurev 
-animal -022513 -114113.
Yu, K., M. Matzapetakis, D. Valent, Y. Saco, A. M. De Almeida, M. 
Terré, and A. Bassols. 2018. Skeletal muscle metabolomics and 
blood biochemistry analysis reveal metabolic changes associated 
with dietary amino acid supplementation in dairy calves. Sci. Rep. 
8:13850. https: / / doi .org/ 10 .1038/ s41598 -018 -32241 -4.
Ahangarani et al.: SHORT COMMUNICATION: GLUTAMIC ACID IN MILK REPLACER
